Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jacquelyn Wittmann
Institution:
Medical College of Wisconsin
Observed institution:
Medical College of Wisconsin
ORCID:
0009-0006-9358-8633
Observed ORCID:
0009-0006-9358-8633
OpenAlex ID:
A5126195961
Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
·
Cancer Research
·
4
PDF
MEK inhibitor–based genomically matched combinatorial targeted therapies in metastatic pancreatic adenocarcinoma with KRAS alterations
2026
·
Elizabeth D Auckley
, Stephanie Yohay
, et al.
·
The Oncologist
·
1
Figure S2 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Figure S4 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Figure S1 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Data from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Figure S6 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Figure S3 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Figure S5 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Show more works
View as search
Works count:
9
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type